logo

Clinical Trial Results

Share

Jan18-up-011818.jpg The following are some of today's top gainers in the pharma/biotech sector.

Jan17-up-011718.jpg The following are some of today's top gainers in the pharma/biotech sector.

Pharma-011518.jpg The following are some of today's top gainers in the pharma/biotech sector.

Pharma-010818.jpg The following are some of the stocks that lost the largest percentage in price today in the pharma/biotech sector.

pharmadaily-011018.jpg The following are some of today's top gainers in the pharma/biotech sector.

pharmalosers-011018.jpg The following are some of the stocks that lost the largest percentage in price today in the pharma/biotech sector.

pharmagainers-011018.jpg What's making news at NVAX, EPZM, GBT and TTOO?

Jan09-down-010918.jpg The following are some of the stocks that lost the largest percentage in price today in the pharma/biotech sector.

Jan09-up-010918.jpg What's making news at PTIE, GBT, ABAX and ASND?

Jan08-down-010818.jpg The following are some of the stocks that lost the largest percentage in price today in the pharma/biotech sector.

Jan08-up-010818.jpg What's making news at ABLX, ALDR, TNDM and PTCT?

Axovant Sciences Ltd. (AXON) said that its investigational drug intepirdine did not meet its primary efficacy endpoints in the Phase 2b HEADWAY and pilot Phase 2 Gait and Balance studies. The company noted that the Intepirdine program will be discontinued based on the MINDSET, HEADWAY, and Gait and Balance...

Jan4-up-010418.jpg What's making news at CCXI, AKAO and APOP?

Jan03-up-010318.jpg What's making news at ARWR, URGN, ARNA, CHRS?

Jan02-UP-010318.jpg What's making news at INSY, APVO, EDIT and MNKD?

Follow RTT